FDA Approves New Type 2 Diabetes Drug Bexagliflozin FDA Approves New Type 2 Diabetes Drug Bexagliflozin
Another SGLT2 inhibitor has been approved for type 2 diabetes based on results from 23 clinical trials that included 5000 patients and more than 300 patients who also had stage 3 chronic kidney disease.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 23, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news
Eli Lilly ’ s Alzheimer ’s Drug Donanemab Fails to Get Early FDA Approval
Eli Lilly & Co.’s bid for accelerated approval of its Alzheimer’s therapy donanemab was rejected by U.S. regulators, an unexpected setback for the drugmaker.
The Food and Drug Administration sent the company a complete response letter saying it would not give the early approval for the drug because not enough patients on the trial had received it for a full 12 months, Lilly said Thursday in a statement.
The agency wanted Lilly to provide safety data on at least 100 patients who had been on the drug for a year. Lilly’s application for accelerated approval was based on a relatively small mid-stage trial...
Source: TIME: Health - January 20, 2023 Category: Consumer Health News Authors: Robert Langreth and Nacha Cattan/Bloomberg Tags: Uncategorized bloomberg wire Drugs Source Type: news
Eating Enough Oily Fish Tied to Lower Risk of Kidney Disease Eating Enough Oily Fish Tied to Lower Risk of Kidney Disease
Adequate consumption of seafood and oily fish may help prevent or delay the development of chronic kidney disease, a new study suggests.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 20, 2023 Category: Cardiology Tags: Nephrology News Source Type: news
High Cardiorespiratory Fitness Linked to Lower Risk for CKD
THURSDAY, Jan. 19, 2023 -- High cardiorespiratory fitness (CRF) levels are associated with a reduced risk for chronic kidney disease (CKD), according to a study published online Jan. 17 in GeroScience.
Setor K. Kunutsor, M.D., Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 20, 2023 Category: Pharmaceuticals Source Type: news
Scientists suggest eating oily fish linked to lower risk of kidney disease
Association found between higher levels of omega 3 fatty acids from seafood and reduced risk of kidney problemsEating at least two portions of oily fish such as mackerel, sardines or herrings a week is linked to a lower risk of chronic kidney disease and a slower decline in the organ ’s function, research suggests.Chronic kidney disease (CKD) affects about 700 million people worldwide. It can lead to kidney failure and death, so there is an urgent need to identify factors that could prevent its onset and progression.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 18, 2023 Category: Science Authors: Andrew Gregory Health editor Tags: Medical research Health Fish Seafood Science Society Source Type: news
Inflammation Drives Residual Risk in Chronic Kidney Disease Inflammation Drives Residual Risk in Chronic Kidney Disease
Which factors more into the risk of major adverse cardiovascular events in statin-treated patients with chronic kidney disease: residual cholesterol risk or inflammation?European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 17, 2023 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Bringing Modernized Kidney Care To The Home: How Monogram Health Is Transforming Polychronic Care
Founded and incubated by Frist Cressey Ventures, Monogram Health is on the forefront of transforming the long stagnant kidney care industry, where more than one in seven adults in the U.S. — nearly 37 million people — are living with chronic kidney disease. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 12, 2023 Category: Pharmaceuticals Authors: Bill Frist, Contributor Tags: Policy /policy Business /business Innovation /innovation Healthcare /healthcare Decision Maker Content decisionmaker Source Type: news
AstraZeneca reaches deal to buy CinCor Pharma for up to $1.8 billion
AstraZeneca entered into a definitive agreement Monday to acquire CinCor Pharma Inc. for up to $1.8 billion.
CinCor (NASDAQ: CINC), based in Waltham, Massachusetts, is developing new treatments for hypertension and chronic kidney disease. The company ’s stock was up 137% at $27.91 per share in early morning trading.
The deal, which still requires shareholder and regulatory approval, is expected to be completed during the first quarter of this year.
CinCor raised $193.6 million with its Nasdaq… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 10, 2023 Category: Health Management Authors: John George Source Type: news
Equitable Drug Access Underpins Diabetes and CKD Guideline Equitable Drug Access Underpins Diabetes and CKD Guideline
A 2022 guideline for treating diabetes in people with chronic kidney disease highlighted the proven value of three underused drug classes and triggered concern over equitable access to these agents.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 9, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Layered Approach Recommended for Patients With Diabetes, CKD
MONDAY, Jan. 9, 2023 -- A layered approach to care is recommended for patients with diabetes and chronic kidney disease (CKD), according to an updated clinical practice guideline published online Jan. 10 in the Annals of Internal Medicine.
Sankar D.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 9, 2023 Category: Pharmaceuticals Source Type: news
AstraZeneca to acquire CinCor Pharma to strengthen cardiorenal pipeline
AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing novel treatments for resistant and uncontrolled hypertension as well as chronic kidney disease. (Source: World Pharma News)
Source: World Pharma News - January 9, 2023 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news
After appeal, East Bay drugmaker snares FDA do-over for dialysis patient drug
A conclusion to the company's rollercoaster journey to win approval of a drug for a subset of chronic kidney disease patients appears closer. But its stock opened down Thursday. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 29, 2022 Category: American Health Authors: Ron Leuty Source Type: news
Opioid Prescribing Practices in Chronic Kidney Disease Opioid Prescribing Practices in Chronic Kidney Disease
A new study looks at opioid prescribing patterns for pain management in patients with chronic kidney disease. Are these drugs being prescribed appropriately?Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 29, 2022 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news
Decision Aid Improves Decision Quality for Seniors With CKD
MONDAY, Dec. 19, 2022 -- For older adults with chronic kidney disease (CKD), a decision aid about kidney replacement therapy improves decision quality and clarifies treatment preferences, according to a study published online Dec. 20 in the Annals... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 19, 2022 Category: Pharmaceuticals Source Type: news
CKD Linked to Greater Neuromuscular Fatigability
MONDAY, Dec. 19, 2022 -- Chronic kidney disease (CKD) is associated with greater neuromuscular fatigability, which increases with fatigue severity, according to a study published online Dec. 9 in Medicine& Science in Sports&... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 19, 2022 Category: Pharmaceuticals Source Type: news
